Literature DB >> 12471397

Measles vaccine effectiveness and risk factors for measles in Dhaka, Bangladesh.

Syed M Akramuzzaman1, Felicity T Cutts, Md J Hossain, Obaidullah K Wahedi, Nazmun Nahar, Darul Islam, Narayan C Shaha, Dilip Mahalanabis.   

Abstract

OBJECTIVE: To evaluate vaccine effectiveness and to assess risk factors for measles in Dhaka, Bangladesh.
METHOD: A case-control study, involving 198 cases with 783 age-matched neighbourhood controls and 120 measles cases with 365 age-matched hospital controls, was conducted in 1995-96 in three large hospitals in Dhaka.
FINDINGS: Measles vaccine effectiveness was estimated at 80% (95% confidence interval (CI) = 60-90%) using neighbourhood controls; very similar results were obtained using hospital controls. Visits to a health facility 7-21 days before onset of any symptoms were associated with increased risk of measles compared with neighbourhood (adjusted odds ratio (OR) = 7.0, 95% CI = 4.2-11.6) or hospital (adjusted OR = 1.7, 95% CI = 1.01-2.8) controls. Cases were more likely than controls to come from a household where more than one child lived (adjusted OR = 1.6, 95% CI = 1.1-2.5 versus neighbourhood controls; adjusted OR = 1.8, 95% CI = 1.02-3.0 versus hospital controls).
CONCLUSIONS: To improve measles control in urban Dhaka missed immunization opportunities must be reduced in all health care facilities by following WHO guidelines. For measles elimination, more than one dose of vaccine would be required.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12471397      PMCID: PMC2567661     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  7 in total

Review 1.  Measles, the need for a paradigm shift.

Authors:  Emilie Javelle; Philippe Colson; Philippe Parola; Didier Raoult
Journal:  Eur J Epidemiol       Date:  2019-10-17       Impact factor: 8.082

2.  Factors contributing to measles transmission during an outbreak in Kamwenge District, Western Uganda, April to August 2015.

Authors:  Fred Nsubuga; Lilian Bulage; Immaculate Ampeire; Joseph K B Matovu; Simon Kasasa; Patricia Tanifum; Alex Ario Riolexus; Bao-Ping Zhu
Journal:  BMC Infect Dis       Date:  2018-01-08       Impact factor: 3.090

3.  Measles outbreaks and Supplemental Immunization Activities (SIAs): the Gwagwalada experience, Abuja 2015.

Authors:  Olukemi Titilope Olugbade; Adeniran Sunday Adeyemi; Adedotun Hadizah Adeoti; Olayinka Stephen Ilesanmi; Saheed Oluwatoyin Gidado; Ndadilnasiya Endie Waziri; Mabel Kamweli Aworh
Journal:  Pan Afr Med J       Date:  2019-01-24

4.  Invalid measles vaccine dose administration and vaccine effectiveness in Ethiopia.

Authors:  Teklay Desta; Ephrem Lemango; Daddi Wayessa; Liya Wondowossen; Mirkuzie Kerie; Balcha Masresha
Journal:  Pan Afr Med J       Date:  2021-12-16

5.  Measles outbreak in Semuto Subcounty, Nakaseke District, Uganda, June-August 2021.

Authors:  Edirisa Juniour Nsubuga; Job Morukileng; Josephine Namayanja; Daniel Kadobera; Fred Nsubuga; Irene Byakatonda Kyamwine; Lilian Bulage; Benon Kwesiga; Alex Riolexus Ario; Julie R Harris
Journal:  IJID Reg       Date:  2022-09-05

6.  Measles outbreak investigation in Zaka, Masvingo Province, Zimbabwe, 2010.

Authors:  Kufakwanguzvarova W Pomerai; Robert F Mudyiradima; Notion T Gombe
Journal:  BMC Res Notes       Date:  2012-12-19

7.  Risk factors for measles death: Kyegegwa District, western Uganda, February-September, 2015.

Authors:  Richardson Mafigiri; Fred Nsubuga; Alex Riolexus Ario
Journal:  BMC Infect Dis       Date:  2017-07-03       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.